Iryna Saranchova
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Iryna Saranchova is currently Chief Clinical Officer at MYND Life Sciences, Inc. since 2021 and Chief Science Officer at Voyageur Pharmaceuticals Ltd. since 2024.
The education history includes a doctorate from the University of British Columbia and a graduate degree from Lviv University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MYND LIFE SCIENCES INC. | Directeur Technique/Scientifique/R&D | 15/05/2021 |
| VOYAGEUR PHARMACEUTICALS LTD. | Directeur Technique/Scientifique/R&D | 17/09/2024 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lviv University
Lviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Ltd. Chemicals: AgriculturalProcess Industries Engages in exploring and development of barite, iodine and fullerene | Process Industries |
MYND Life Sciences, Inc.
MYND Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national